Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial.

导出 LinkOut

翻译打印收藏纠错

作者： Alan M,Laties ^[1] ; Allan J,Flach ^[2] ; Irina,Baldycheva ^[3] ; Ihor,Rak ^[3] ; Willie,Earley ^[3] ; Sanjeev,Pathak ^[3]

作者单位： University of Pennsylvania, Philadelphia, PA, USA laties@mail.med.upenn.edu. ^[1] University of California, San Francisco, CA, USA. ^[2] AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA - former employee. ^[3]

关键词 Cataractogenic potential non-inferiority trial open-label quetiapine risperidone

主题词青少年(Adolescent);成年人(Adult);老年人(Aged);抗精神病药(Antipsychotic Agents);白内障(Cataract);二苯硫氮|艹卓|类(Dibenzothiazepines);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);精神病(Psychotic Disorders);利哌立酮(Risperidone);精神分裂症(Schizophrenia);治疗结果(Treatment Outcome);青年人(Young Adult)

DOI 10.1177/0269881114553253

PMID 25315830

发布时间 2015-11-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览30

Journal of psychopharmacology (Oxford, England)

2015年29卷1期

69-79页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial.

Journal of psychopharmacology (Oxford, England)

相似文献

Journal of psychopharmacology (Oxford, England)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial.

Journal of psychopharmacology (Oxford, England)

相似文献

Journal of psychopharmacology (Oxford, England)

相关期刊

检索历史清除